University of California San Francisco
San Francisco, California, 94158, United States
Location status: Recruiting
NCT Number: NCT03698149
Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Not applicable
San Francisco, California, 94158, United States
Location status: Recruiting
ECoG is a type of electrophysiological monitoring that uses electrodes placed directly on the exposed surface of the brain to record electrical activity. With this ECoG-based neural interface, study patients will undergo training and assessment of their ability to control a complex robotic system and to determine if ECoG brain signals can be used to produce speech.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PMT Subdural Cortical Electrodes/Blackrock NeuroPort Array and NeuroPort System
Time frame: Up to 6 years post-implant period
The primary endpoint of this study is to determine the incidence of treatment-emergent adverse events associated with the ECoG-based interface
Time frame: Up to 6 years post-implant period
To enable communication via text decoded from neural signals.
Time frame: Up to 6 years post-implant period
To enable communication via synthesized speech decoded from neural signals.
Time frame: Up to 6 years post-implant period
To evaluate communication via text decoded from neural signals.
Time frame: Up to 6 years post-implant period
To evaluate communication via synthesized speech decoded from neural signals.
Contact information is provided by the study sponsor or research team.
Karunesh Ganguly
Other
A High-Performance ECoG-based Neural Interface for Communication and Neuroprosthetic Control
Acronym: BRAVO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02795052
ALS, Alzheimer Disease
Westport, Connecticut, United States
View Trial DetailsNCT07460037
ALS, Aphasia
Hangzhou, Zhejiang, China
View Trial DetailsNCT06203106
ALS, Adnexal Diseases
New York, United States
View Trial DetailsNCT01393444
ALS, Brachial Plexus Injury
Pittsburgh, Pennsylvania, United States
View Trial Details